BCL2L1 and colorectal carcinoma: We found that both MCL-1 and BCL-XL are highly expressed in BRAFV600E CRC cell lines and that combining BRAF inhibitors with BCL-XL inhibitors significantly enhances apoptosis in these cell lines.